David Reddy
Amministratore Delegato presso MMV Medicines for Malaria Venture
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Albert Bourla | M | 62 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Sophie O'Connor | F | 54 |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | - |
Yuli Ismartono | F | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Elizabeth J. Linder | F | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Philip Thomas | M | 63 |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | - |
Thomas Schinecker | M | 49 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 1 anni |
Alan Court | M | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
David Brandling-Bennett | M | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Michael Ferguson | M | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Winston E. Gutteridge | M | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | 15 anni |
Antonio Esteve Cruella | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Dennis Schmatz | M | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Joy Phumaphi | F | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Wendy R. Sanhai | M | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Azra Ghani | M | - |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | - |
Andrew Cook | M | - |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | 7 anni |
Simon Bland | M | - |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | - |
Eva Thorne | M | - |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | - |
James Whiting | M | - |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | 12 anni |
Mathew van Lierop | M | - |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | 7 anni |
Robert Newman | M | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Dieter Weinand | M | 63 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Konji Sebati | M | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Gabriel Jaramillo-Sanint | M | 74 |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Ian Read | M | 71 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Stefan Oschmann | M | 67 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Per Wold-Olsen | M | 76 |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Hans Jörg Reinhardt | M | 68 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 14 anni |
Olivier Brandicourt | M | 68 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
His Royal Highness The Prince of Wales Windsor | M | 75 |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | - |
Tapan Durgadas Ray | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Norman Mbazima | M | 65 |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | 4 anni |
Andrea Buscaglia | M | 60 |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Ulf Arne Wiinberg | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Jorge Gallardo Ballart | M | 82 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 20 anni |
Severin Schwan | M | 57 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 8 anni |
Dominique Limet | M | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Paola Ricci | F | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Ugo di Francesco | M | 63 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Sunao Manabe | M | 69 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 1 anni |
Baroness Hayman Hayman | F | 75 |
Malaria No More UK
Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | 5 anni |
Roger Connor | M | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Andrea Lucard | F | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Thomas Cueni | M | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 7 anni |
Gilbert Marks | M | 66 |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | 4 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Svizzera | 34 | 75.56% |
Regno Unito | 11 | 24.44% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- David Reddy
- Contatti personali